journal of biomedical informatics
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

The Impact of Telemedicine and Digital Health on Healthcare Delivery Systems

Emma Thompson*
 
Department of Biomedical Informatics, Massachusetts Institute of Technology, USA, Email: ethompson@informatics.mit.edu
 
*Correspondence: Emma Thompson, Department of Biomedical Informatics, Massachusetts Institute of Technology, USA, Email: ethompson@informatics.mit.edu

Published: 27-Dec-2024, DOI: 10.24105/ejbi.2024. 20(4): 290-291

This open-access article is distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC) (http://creativecommons.org/licenses/by-nc/4.0/), which permits reuse, distribution and reproduction of the article, provided that the original work is properly cited and the reuse is restricted to noncommercial purposes. For commercial reuse, contact submissions@ejbi.org

European Journal of Biomedical Informatics

Abstract

   

Introduction

Telemedicine and digital health have revolutionized healthcare delivery systems in recent years, dramatically altering the way care is provided, accessed, and managed [1]. These technologies leverage the power of information technology to bridge the gaps between healthcare providers and patients, transcending geographical and logistical limitations. This transformation has had a profound impact on healthcare, influencing its accessibility, efficiency, quality, and cost [2].

One of the most significant impacts of telemedicine and digital health is the enhanced access to healthcare services. Telemedicine enables patients to consult with healthcare providers remotely, eliminating the need for travel and making healthcare more accessible to those in rural or underserved areas [3]. Patients can now receive medical consultations, diagnoses, and prescriptions through video calls, phone calls, or even text-based communication, providing a more convenient option for those who may face physical or financial barriers to in-person visits. Digital health tools, such as mobile health applications and remote monitoring devices, also allow individuals to track their health conditions, receive timely interventions, and manage chronic diseases from the comfort of their homes [4].

Telemedicine and digital health offer potential cost-saving benefits for both healthcare providers and patients. For providers, telemedicine allows them to conduct consultations without the overhead costs associated with maintaining physical office spaces [5]. Virtual consultations can be scheduled with greater flexibility, leading to more efficient use of healthcare resources and a reduction in the time patients spend in waiting rooms. From a patient’s perspective, telemedicine eliminates the need for transportation costs, time off work, and associated expenses of in-person visits. Digital health technologies further contribute to cost savings by promoting preventive care and chronic disease management, reducing the need for costly hospitalizations and emergency room visits [6].

Telemedicine and digital health technologies contribute to improving the quality of care by facilitating more timely interventions, increasing patient engagement, and enabling continuous monitoring of health conditions. Through telemedicine, healthcare providers can follow up on treatments, track recovery progress, and make adjustments to care plans in real time [7]. Moreover, the use of electronic health records (EHRs) and integrated health systems enhances the accuracy of patient information, reduces the likelihood of errors, and streamlines care coordination. Digital health tools such as wearable devices and mobile applications enable patients to actively monitor their health and share real-time data with their healthcare providers, fostering a more collaborative approach to care [8].

The healthcare industry has long faced challenges related to physician shortages, particularly in rural areas, where healthcare professionals may be in short supply. Telemedicine and digital health offer a potential solution by enabling healthcare providers to reach a larger number of patients without the constraints of physical space and location. Providers can offer consultations across state lines, enhancing their ability to treat patients in regions where their expertise might be lacking. Additionally, telemedicine facilitates a more flexible work-life balance for healthcare professionals, which may help reduce burnout and improve retention in the healthcare workforce [9].

Despite the many benefits, there are several challenges and barriers to the widespread adoption of telemedicine and digital health. Privacy and security concerns remain paramount, as the transmission of sensitive medical data over digital platforms could be vulnerable to cyberattacks or breaches. Legal and regulatory issues, such as licensure requirements and reimbursement policies, also complicate the use of telemedicine across different states or countries. Moreover, there are concerns about the digital divide, as certain populations may not have access to the necessary technology or internet connectivity to benefit from these services [10].

Conclusion

Telemedicine and digital health have undoubtedly transformed healthcare delivery, making it more accessible, efficient, and cost-effective while improving the overall quality of care. However, to fully realize the potential of these technologies, continued investment in infrastructure, policy reforms, and the adoption of cybersecurity measures are essential. With the proper safeguards in place, telemedicine and digital health have the power to create a more inclusive, patient-centered healthcare system, ultimately benefiting both providers and patients alike.

References

  1. Iqbal MA, Hong K, Kim JH, Choi Y. Severe combined immunodeficiency pig as an emerging animal model for human diseases and regenerative medicines. BMB reports. 2019;52(11):625.

    2. Indexed at, Google Scholar, Cross Ref

  2. Hultqvist M, Backlund J, Bauer K, Gelderman KA, Holmdahl R. Lack of reactive oxygen species breaks T cell tolerance to collagen type II and allows development of arthritis in mice. J Immunol. 2007;179(3):1431-1437.

    3. Indexed at, Google Scholar, Cross Ref

  3. Bendle GM, Linnemann C, Hooijkaas AI, Bies L, de Witte MA, Jorritsma A, et al. Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy. Nat Med. 2010;16(5):565-570.

    4. Indexed at, Google Scholar, Cross Ref

  4. Guo H, Santiago F, Lambert K, Takimoto T, Topham DJ. T-cell-mediated protection against lethal 2009 pandemic H1N1 influenza virus infection in a mouse model. J Virol. 2011;85(1):448-455.

    5. Indexed at, Google Scholar, Cross Ref

  5. Boettcher AN, Li Y, Ahrens AP, Kiupel M, Byrne KA, Loving CL, et al. Novel engraftment and T cell differentiation of human hematopoietic cells in ART-/- IL2RG-/Y SCID pigs. Front Immunol. 2020;11:100.

    6. Indexed at, Google Scholar, Cross Ref

  6. Vargo D, Zhu L, Benwell B, Yan Z. Digital technology use during COVID-19 pandemic: A rapid review. Hum Behav Emerg. 2021;3(1):13-24.

    7. Indexed at, Google Scholar, Cross Ref

  7. Golinelli D, Boetto E, Carullo G, Nuzzolese AG, Landini MP, Fantini MP. Adoption of digital technologies in health care during the COVID-19 pandemic: systematic review of early scientific literature. J Med Internet Res. 2020; 6;22(11):e22280.

    8. Indexed at, Google Scholar, Cross Ref

  8. Haleem A, Javaid M, Singh RP, Suman R. Applications of Artificial Intelligence (AI) for cardiology during COVID-19 pandemic. Sustain Oper Compu. 2021;2:71-78.

    9. Indexed at, Google Scholar, Cross Ref

  9. Khuntia J, Ning X, Stacey R. Digital Orientation of Health Systems in the Post–COVID-19 “New Normal” in the United States: Cross-sectional Survey. J Med Internet Res. 2021;23(8):e30453.

    10. Indexed at, Google Scholar, Cross Ref

  10. Khozeimeh F, Sharifrazi D, Izadi NH, Joloudari JH, Shoeibi A, Alizadehsani, R et al. A Combining a convolutional neural network with autoencoders to predict the survival chance of COVID-19 patients. Sci Rep. 2021;11(1):1-8.

    11. Indexed at, Google Scholar, Cross Ref